Key Events This Week
27 Apr: Stock opens strong at Rs.2,494.00 (+4.13%)
28 Apr: Minor correction to Rs.2,468.15 (-1.04%)
29 Apr: Recovery to Rs.2,500.50 (+1.31%)
30 Apr: New 52-week and all-time high at Rs.2,710.55; closes at Rs.2,596.55 (+3.84%)
27 April: Strong Opening with 4.13% Gain
Acutaas Chemicals began the week on a positive note, surging 4.13% to close at Rs.2,494.00 on 27 April 2026. This gain outpaced the Sensex’s 1.14% rise to 35,751.09, signalling early bullish sentiment. The stock’s volume of 47,105 shares indicated healthy investor interest, setting the tone for the week ahead.
28 April: Minor Pullback Amid Market Consolidation
The stock experienced a slight correction on 28 April, slipping 1.04% to Rs.2,468.15, while the Sensex declined 0.28% to 35,650.27. The reduced volume of 16,886 shares suggested a pause in momentum, possibly reflecting profit-taking or consolidation after the prior day’s strong advance.
29 April: Recovery and Resilience
On 29 April, Acutaas Chemicals rebounded, gaining 1.31% to Rs.2,500.50, outperforming the Sensex’s 0.45% increase to 35,811.60. The volume picked up to 21,213 shares, indicating renewed buying interest. This recovery reinforced the stock’s underlying strength ahead of key events later in the week.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
30 April: Record-Breaking Surge to New Highs
The highlight of the week came on 30 April 2026, when Acutaas Chemicals Ltd surged 3.84% to close at Rs.2,596.55, hitting an intraday 52-week high of Rs.2,710.55 and an all-time high of Rs.2,688.70. This remarkable performance occurred despite the Sensex declining 0.83% to 35,515.95, underscoring the stock’s strong relative strength.
Intraday volatility was elevated at 5.79%, reflecting active trading and investor enthusiasm. The stock outperformed its Pharmaceuticals & Biotechnology sector peers by nearly 7%, highlighting its leadership within the industry. Volume surged to 108,271 shares, the highest of the week, confirming robust market participation.
Technical indicators supported this bullish momentum, with the stock trading above all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day). Weekly and monthly MACD, KST, and On-Balance Volume (OBV) readings were bullish, signalling sustained upward momentum.
Q4 FY26 Results: Stellar Profit Growth
Acutaas Chemicals reported outstanding financial results for the December 2025 quarter, which likely contributed to the strong price action. Net sales reached ₹393.18 crores, with a profit before depreciation, interest, and tax (PBDIT) of ₹150.65 crores. Operating profit margin stood at a robust 38.32%, while profit before tax excluding other income was ₹139.97 crores.
Net profit after tax surged 111% to ₹107.96 crores, with earnings per share (EPS) at ₹13.19, marking the sixth consecutive quarter of positive earnings. These results underscore the company’s operational efficiency and growth trajectory, reinforcing investor confidence.
Acutaas Chemicals Ltd caught your attention? Explore our comprehensive research report with in-depth analysis of this small-cap stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth small-cap analysis
- - Valuation assessment included
Weekly Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-27 | Rs.2,494.00 | +4.13% | 35,751.09 | +1.14% |
| 2026-04-28 | Rs.2,468.15 | -1.04% | 35,650.27 | -0.28% |
| 2026-04-29 | Rs.2,500.50 | +1.31% | 35,811.60 | +0.45% |
| 2026-04-30 | Rs.2,596.55 | +3.84% | 35,515.95 | -0.83% |
Key Takeaways
Strong Relative Performance: Acutaas Chemicals outperformed the Sensex by 3.71% over the week, demonstrating resilience amid a broadly bearish market environment.
Record Highs and Technical Strength: The stock hit new 52-week and all-time highs, supported by bullish technical indicators and trading above all major moving averages.
Robust Financial Results: The stellar Q4 FY26 earnings, with a 111% profit surge and strong margins, provided a solid fundamental underpinning for the price rally.
Institutional Confidence and Quality Metrics: With a Mojo Score of 82.0 and a Strong Buy grade, alongside net-debt free status and efficient asset utilisation, the company’s fundamentals remain robust despite premium valuation multiples.
Conclusion
Acutaas Chemicals Ltd’s 8.41% weekly gain reflects a confluence of strong financial performance, technical momentum, and institutional backing. The stock’s ability to deliver substantial returns while the broader market faced headwinds highlights its standout position within the Pharmaceuticals & Biotechnology sector. Although valuation metrics suggest a premium, these are justified by consistent earnings growth and operational excellence. Investors monitoring this small-cap stock will note its sustained upward trajectory and quality fundamentals as key factors shaping its market performance.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
